Transform drug discovery with predictive human organ models
We are an Organ-on-a-chip company that enables you to generate human-specific efficacy, ADME and safety data with pioneering PhysioMimix® solutions

Introducing
PhysioMimix® Core
This launch combines our single-organ, multi-organ, and high-throughput configurations within one scalable platform.
Areas to explore
New approach methodologies (NAMs), including Organ-on-a-chip (OOC), represent the key to faster, more accurate drug discovery. Explore how to harness the power of PhysioMimix® Core in your lab, or via our contract research services.

Products
Learn more about PhysioMimix® Core and why it’s helping drive OOC adoption

Applications
Explore our highly characterized and validated PhysioMimix® Core applications

Technology
Discover why the technology that powers PhysioMimix is like no other
PhysioMimix® Core: Mimics human physiology like no other
PhysioMimix Core models human-specific biology, which animals lack. Unlock effects that manifest only in human tissue to improve the accuracy and efficiency of drug discovery
- Human-relevant, translatable data
- Single-, multi-organ and higher throughput capabilities
- Flexible and customizable
- Easy to adopt, simple to use
- Broad drug modality compatibility, including monoclonal antibodies, oligonucleotides and traditional small molecules

10+
years of OOC industry experience and know-how
70%
of our employees are scientists and engineers
16/20
top pharmaceutical companies use PhysioMimix®
Using the PhysioMimix® System is really straightforward; with a little practice, any tissue culture scientist can master the skills needed for Organ-on-a-chip (OOC) assays
Dr. Déborah Lenart
Research Scientist, Charles River Laboratories
What’s new?
Resources

New Scientific publication
A primary human Gut/Liver microphysiological system to estimate human oral bioavailability…
Industry news

3Rs project with FDA
CN Bio to participate in 3Rs Collaborative-lead project with FDA to build confidence in Liver MPS for DILI…
Partnerships

PhysioMimix data for Inipharm
PhysioMimix® Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment…
Press release

PhysioMimix Core launch
CN Bio launches all-in-one microphysiological system, PhysioMimix® Core, for future-proofed Organ-on-a-chip research

